BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

17 related articles for article (PubMed ID: 890840)

  • 1. Author Correction: Cancer cell metabolism and antitumour immunity.
    De Martino M; Rathmell JC; Galluzzi L; Vanpouille-Box C
    Nat Rev Immunol; 2024 Jul; 24(7):537. PubMed ID: 38806693
    [No Abstract]   [Full Text] [Related]  

  • 2. Historical Perspective and Current Trends in Anticancer Drug Development.
    Gach-Janczak K; Drogosz-Stachowicz J; Janecka A; Wtorek K; Mirowski M
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of drug enantiomers in clinical pharmacology.
    Williams K; Lee E
    Drugs; 1985 Oct; 30(4):333-54. PubMed ID: 3905334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluoro- and 5-chlorocyclophosphamide: synthesis, metabolism, and antitumor activity of the cis and trans isomers.
    Foster AB; Jarman M; Kinas RW; van Maanen JM; Taylor GN; Gaston JL; Parkin A; Richardson AC
    J Med Chem; 1981 Dec; 24(12):1399-403. PubMed ID: 7310816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The microsomal metabolism of some analogues of cyclophosphamide: 4-methylcyclophosphamide and 6-methylcyclophosphamide.
    Cox PJ; Farmer PB; Jarman M
    Biochem Pharmacol; 1975 Mar; 24(5):599-606. PubMed ID: 1125063
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamide.
    Abel G; Cox PJ; Farmer PB; Haskins NJ; Jarman M; Meral K; Stec WJ
    Cancer Res; 1978 Aug; 38(8):2592-9. PubMed ID: 667853
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and antitumor activity of 6-trifluoromethylcyclophosphamide and related compounds.
    Farmer PB; Cox PJ
    J Med Chem; 1975 Nov; 18(11):1106-10. PubMed ID: 1177256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
    Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
    Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
    Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
    Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.